Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Aug 05, 2026
Why Is Resideo Technologies (REZI) Stock Down -27.77% Today?

Why Is Resideo Technologies (REZI) Stock Down -27.77% Today?

Key Takeaways

  • REZI shares fell 27.77% on Monday, closing at $26.17 after the prior session's close of $36.23, driven primarily by the completion of a major corporate spin-off.
  • The decline reflects the mechanical price adjustment following the separation of ADI Global Distribution, which began trading on the NYSE under the ticker ADIG.
  • Resideo used a $900 million dividend from ADI to repay term-loan debt, with an additional $200 million repayment planned by the end of the third quarter.
  • Trading volume surged to 3.42 million shares, more than double the average daily volume of approximately 1.57 million.
  • Resideo now operates as a pure-play building technologies company, with Q2 2026 earnings scheduled for release on August 12.

Opening Summary

REZI, Resideo Technologies, Inc. — a global provider of comfort, energy management, and security solutions for residential and commercial end markets — saw its shares plunge 27.77% during Monday's trading session. The stock closed at $26.17, down from a prior session close of $36.23, as the company officially completed the long-planned spin-off of its ADI Global Distribution segment. The newly independent ADI began regular-way trading Monday on the New York Stock Exchange under the symbol ADIG, marking a watershed moment that reshapes Resideo into a focused building technologies company while recalibrating its equity valuation to reflect the separated distribution business.

The ADI Global Distribution Spin-Off: A Transformational Corporate Action

The overwhelming driver behind Monday's sharp decline in REZI shares was the completion of the ADI Global Distribution spin-off, which took effect after the close of trading on August 3. Under the terms of the separation, Resideo shareholders of record as of July 20, 2026, received one share of ADI common stock for every two shares of Resideo common stock held. The distribution was structured as a tax-free dividend to Resideo shareholders for U.S. federal income tax purposes, with cash paid in lieu of fractional shares.

In spin-off transactions, the parent company's share price typically drops by a magnitude roughly equivalent to the market's assessment of the separated entity's value. Monday's 27.77% decline does not represent a loss of value for existing shareholders in a conventional sense — those shareholders now own positions in both REZI and ADIG, with the combined value theoretically approximating the pre-spin market capitalization. However, the inherent uncertainty around how the two entities will trade independently, combined with the complexity of investor portfolio rebalancing, contributed to volatile price discovery throughout the session.

ADI Global Distribution enters independence as a formidable player: the company generated $4.8 billion in revenue in 2025, employs approximately 4,100 team members, offers more than 500,000 products from over 1,000 suppliers, and serves more than 100,000 customers through nearly 200 global store locations. The business is a leading distributor of professionally installed low-voltage products spanning security, residential and professional audio-visual, fire and life safety, and data communications categories.

Balance Sheet Overhaul: $900 Million Debt Paydown

A critical component of the spin-off transaction involved a substantial deleveraging of Resideo's balance sheet. ADI financed part of the separation using proceeds from a $400 million senior notes offering and borrowings under a $600 million term loan facility, which enabled a one-time $900 million cash dividend to Resideo. The company immediately applied that cash to repay outstanding principal under its Term Loan B credit facility, with an additional approximately $200 million repayment expected by the end of the third fiscal quarter following post-closing cash adjustments.

Additionally, Resideo reduced its outstanding Series A Cumulative Convertible Participating Preferred Stock by 150,000 shares, leaving 350,000 shares outstanding with a proportional adjustment to the conversion price. The company also amended its investment and registration rights agreements with private equity firm CD&R, extending the lock-up on CD&R's holdings to August 3, 2028, which provides a measure of structural stability for the remaining shareholder base.

While debt reduction is strategically positive — lowering interest costs and improving financial flexibility — the near-term optics of a smaller, leaner Resideo contributed to the stock's repositioning in a lower trading range, as investors digest what the pure-play entity looks like on a standalone basis.

Market Context and Trading Activity

Volume on Monday was exceptionally heavy, with approximately 3.42 million shares changing hands compared to the 90-day average of roughly 1.57 million, reflecting heightened investor engagement with the newly separated structure. The stock opened at $26.00, touched an intraday low of $25.50 — within striking distance of its 52-week low of $25.37 — and briefly rallied to $27.35 before settling at $26.17.

The move occurred in a vacuum relative to the broader market, as the price action was almost entirely driven by the corporate separation rather than sector-wide dynamics or macroeconomic forces. Resideo's 200-day simple moving average stood at approximately $34.63 prior to the spin, and the stock now trades well below that level, placing it in technically uncharted territory following the structural reset.

In extended-hours trading, REZI edged modestly higher to around $26.57, suggesting some stabilization as the market begins to absorb the post-spin valuation.

What Comes Next for REZI

The spotlight now shifts to Resideo's second-quarter 2026 earnings report, scheduled for release after the market closes on August 12. Analysts are currently forecasting earnings of $0.68 per share on revenue of $1.94 billion — figures that fall below the company's own Q2 EPS guidance range of $0.71 to $0.75. The results will mark Resideo's first quarterly report as a pure-play building technologies company, and investors will be scrutinizing both the top-line performance and margin trajectory of the streamlined business.

Wall Street sentiment ahead of the spin-off was mixed. Morgan Stanley lowered its price target on REZI from $50 to $45 while maintaining an Overweight rating, while Zacks Research downgraded the stock to a Strong Sell in early July. Seaport Research Partners initiated coverage with a Buy rating and a $55 price objective. Analyst consensus now stands at Hold with an average target of $46.50, though these ratings and targets will likely be recalibrated by the analyst community to reflect the post-spin corporate structure.

Key risks for the newly independent Resideo include its remaining debt load, which — while substantially reduced — still represents meaningful leverage for a company with recent net income losses. The effectiveness of management's execution in capturing the profitable growth and margin expansion promised by the pure-play focus will be a critical narrative in the quarters ahead. Additionally, any softening in residential housing markets or professional installation demand could pressure revenue growth.

Trending AI Robots

For traders and investors navigating market-moving events like corporate spin-offs, automated tools can offer a disciplined edge. Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers — each employing distinct strategies, timeframes, and performance metrics — the platform highlights only those algorithms that are outperforming right now. Explore the Trending AI Robots page to see which strategies are gaining traction in today's dynamic market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: REZI

REZI sees MACD Histogram just turned negative

REZI saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where REZI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REZI as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

REZI moved below its 50-day moving average on August 04, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where REZI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for REZI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The 10-day moving average for REZI crossed bullishly above the 50-day moving average on July 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REZI advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

REZI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 265 cases where REZI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. REZI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.624) is normal, around the industry mean (4.778). P/E Ratio (87.433) is within average values for comparable stocks, (155.050). REZI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.058). REZI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.518) is also within normal values, averaging (1.648).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REZI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.

Notable companies

The most notable companies in this group are Fastenal Co (NASDAQ:FAST).

Industry description

Electronics distributors are companies that are involved in distribution of one or more of the following: electronic components, computer products/ peripherals and software products & services. Several electronics distributors are also becoming the point of contact for technical/pre- & post-sale support in many cases, in an attempt to bolster their position in the market. Tariffs and/or cross-border trade barriers are some of the potential threats to the electronics supply chain, but that could also potentially lead to re-directing to markets where tariffs/restrictions are lower depending on demand. The industry is also vulnerable in the event of economic slowdowns. Arrow Electronics, Inc., SYNNEX Corporation and Versum Materials, Inc. are some of the major electronics distributors in the U.S.

Market Cap

The average market capitalization across the Electronics Distributors Industry is 13.1B. The market cap for tickers in the group ranges from 23.01K to 61.4B. GWW holds the highest valuation in this group at 61.4B. The lowest valued company is OMPS at 23.01K.

High and low price notable news

The average weekly price growth across all stocks in the Electronics Distributors Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 1%. WCC experienced the highest price growth at 13%, while REZI experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Electronics Distributors Industry was 158%. For the same stocks of the Industry, the average monthly volume growth was 101% and the average quarterly volume growth was 181%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 56
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 68
Seasonality Score: -41 (-100 ... +100)
View a ticker or compare two or three
REZI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of household security solutions

Industry ElectronicsDistributors

Profile
Details
Industry
Miscellaneous Commercial Services
Address
16100 North 71st Street
Phone
+1 480 573-5340
Employees
14000
Web
https://www.resideo.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.